GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » EKIMAS Corp (OTCPK:ASNB) » Definitions » Days Sales Outstanding

EKIMAS (EKIMAS) Days Sales Outstanding : 0.00 (As of Dec. 2022)


View and export this data going back to 1996. Start your Free Trial

What is EKIMAS Days Sales Outstanding?

EKIMAS's average Accounts Receivable for the three months ended in Dec. 2022 was $0.00 Mil. EKIMAS's Revenue for the three months ended in Dec. 2022 was $0.00 Mil.

The historical rank and industry rank for EKIMAS's Days Sales Outstanding or its related term are showing as below:

ASNB's Days Sales Outstanding is not ranked *
in the Diversified Financial Services industry.
Industry Median: 61.845
* Ranked among companies with meaningful Days Sales Outstanding only.

EKIMAS's Days Sales Outstanding stayed the same from Dec. 2021 (0.00) to Dec. 2022 (0.00).


EKIMAS Days Sales Outstanding Historical Data

The historical data trend for EKIMAS's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EKIMAS Days Sales Outstanding Chart

EKIMAS Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 50.22 67.50 - - -

EKIMAS Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of EKIMAS's Days Sales Outstanding

For the Shell Companies subindustry, EKIMAS's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EKIMAS's Days Sales Outstanding Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, EKIMAS's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where EKIMAS's Days Sales Outstanding falls into.



EKIMAS Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

EKIMAS's Days Sales Outstanding for the fiscal year that ended in Mar. 2022 is calculated as

Days Sales Outstanding (A: Mar. 2022 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2021 ) + Accounts Receivable (A: Mar. 2022 )) / count ) / Revenue (A: Mar. 2022 )*Days in Period
=( (0 + 0) / 1 ) / 0*365
=0 / 0*365
=N/A

EKIMAS's Days Sales Outstanding for the quarter that ended in Dec. 2022 is calculated as:

Days Sales Outstanding (Q: Dec. 2022 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2022 ) + Accounts Receivable (A: Dec. 2022 )) / count ) / Revenue (A: Dec. 2022 )*Days in Period
=( (0 + 0) / 1 ) / 0*365 / 4
=0 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


EKIMAS  (OTCPK:ASNB) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


EKIMAS Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of EKIMAS's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


EKIMAS (EKIMAS) Business Description

Traded in Other Exchanges
N/A
Address
3651 Lindell Road, Suite D565, Las Vegas, NV, USA, 89103
EKIMAS Corp is a shell company.
Executives
Partners Aps Gk 10 percent owner MESTERLODDEN 3B, GENTOFTE G7 2820
Henrik Oerbekker 10 percent owner 94, RUE DES AUBEPINES, L-1145, LUXEMBOURG N4 2449
Henrik Rouf 10 percent owner 468 N. CAMDEN DR., SUITE 350, BEVERLY HILLS CA 90210
Khristine L Carroll officer: EVP Commercial Operations 229 ANDOVER STREET, WILMINGTON MA 01887
Michael F Adams director, officer: Chief Executive Officer 78 E OLYMPIA AVE, C/O CARDIO TECH INTERNATIONAL INC, WOBURN MA 01810-2057
David Crispino Volpe officer: Chief Financial Officer 235 STONEBRIDGE DRIVE, NASHUA NH 03063
Michael L Barretti director 78 E OLYMPIA AVE, C/O CARDIO TECH INTERNATIONAL INC, WOBURN MA 01810-2057
Oneill William J Jr director 4000 HOLLYWOOD BLVD STE 650N, HOLLYWOOD FL 33021
Mark R Tauscher director
Eric G Walters officer: Vice President and CFO C/O MFIC CORP, 30 OSSIPEE RD., NEWTON MA 02464
Andrew Martin Reed officer: VP of Science and Technology 12106 WEST 75TH LANE, ARVADA CO 80005
Philip Alan Beck other: General manager 1230 CREEKSIDE CROSSING, STILLWATER MN 55082
Jeremiah E Dorsey director P.O. BOX 910, QUECHEE VT 05059
Leslie M Taeger officer: CFO
Douglas E Whittaker officer: President Gish Biomedical